Search clinical trials for: Palbociclib administered Fasted

Total 12118 results

Assistance Publique - Hôpitaux de Paris

Unknown

A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer (PALPETBIO)

Breast Cancer | Metastasis | HR+/HER2-negative Breast Cancer
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Recruiting

Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

Advanced Solid Tumor

Netherlands
BTG International Inc.

Terminated

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Belgium
GlaxoSmithKline

Completed

A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A

Asthma

United Kingdom
Pfizer

Completed

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

Metastatic Breast Cancer

United States
Fernando Moreno Antón

Completed

Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use Programe (PALBOCOMP)

Breast Cancer

Spain
Peking University Cancer Hospital & Institute
Kiang Wu Hospital

Unknown

Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations

Melanoma
Samsung Medical Center

Unknown

A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor

Thymic Cancer

Korea, Republic of
EyePoint Pharmaceuticals, Inc.

Completed

Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis (MkII)

Non-Infectious Uveitis

United States
Lebanese University
Haykel Hospital

Recruiting

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA (PTST_PALBEVA)

Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Chemotherapy | Solid Tumor | Immunotherapy | Targeted Therapy | Precision Therapy

Lebanon
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Terminated

Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer

HER2-positive Metastatic Breast Cancer

China
Ege University

Completed

Different Types of Electrostimulation Probes During IONM

Thyroid Diseases
Yale University

Completed

Directly Observed Therapy for Community-Released HIV+ Prisoners (Connect)

HIV/AIDS | Substance Abuse

United States
Sunnybrook Health Sciences Centre
Pfizer; Canadian Institutes of Health Research (CIHR)

Completed

Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples (DREAM3)

Hypertension | Diabetes Mellitus
Samsung Medical Center
Korean Cancer Study Group

Recruiting

High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)

Breast Cancer

Korea, Republic of
Grupo Espanol de Investigacion en Sarcomas

Recruiting

Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (PalboSarc)

Osteosarcoma | Chordoma | Soft-tissue Sarcoma

Spain
Georgetown University
Pfizer

Terminated

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery (WI223281)

DCIS

United States
Rush University Medical Center

Completed

Patterns of Prescribing and Monitoring of Palbociclib

Advanced Breast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
University Hospital Heidelberg

Completed

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)

Chordoma

Germany
Pfizer
Eli Lilly and Company

Completed

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Osteoarthritis | Cancer Pain | Recurrent Low Back Pain

United States
Mercy Research

Completed

Patient Anxiety Associated With Lymphedema Surveillance Method

Anxiety

United States
Mt. Sinai Medical Center, Miami
MedImmune LLC

Completed

Subcutaneous Amifostine Safety Study

Lymphoma | Head and Neck Cancer | Lung Cancer

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults

Zika Virus

United States
Pfizer

Recruiting

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Breast Cancer

Japan
Peter MacCallum Cancer Centre, Australia

Recruiting

Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE (CELEBRATE)

Melanoma | Metastasis

Australia
Memorial Sloan Kettering Cancer Center
Incyte Corporation

Active, not recruiting

Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

Well-differentiated/Dedifferentiated Liposarcoma

United States
Pfizer

Completed

A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs

Breast Cancer

Canada
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Northwestern University; Northwell Health; Dana-Farber... and other collaborators

Active, not recruiting

BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia

Hairy Cell Leukemia

United States
Pfizer

Completed

An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.

Lymphoma, Mantle-Cell

United States
Latin American Cooperative Oncology Group
Pfizer

Completed

Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer (LACOG1018)

Ovarian Cancer

Brazil
Prolong Pharmaceuticals

Recruiting

Safety Study of PP-007 in Subjects With Acute Ischemic Stroke (HEMERA-1)

Acute Ischemic Stroke

United States
Afferent Pharmaceuticals, Inc.

Completed

A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)

Refractory Chronic Cough
Yale University

Completed

Directly Observed Antiretroviral Therapy Among Active Drug Users

HIV/AIDS | Substance Abuse

United States
Zhejiang Cancer Hospital
Pfizer

Recruiting

Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients

Breast Neoplasms

China
Grupo Español de Investigación en Neurooncología
Pfizer

Completed

Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved

Oligoastrocytoma | Oligodendroglioma

Spain
University of Texas Southwestern Medical Center
University of Pennsylvania; Pfizer

Completed

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Advanced Breast Cancer

United States
Oklahoma State University Center for Health Sciences
Oral Roberts University

Recruiting

Interactive Voice Based Administration of the GAD 7

General Anxiety Disorder

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

HIV-1 Infection

United States, Puerto Rico
Pfizer
Eli Lilly and Company

Completed

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

Osteoarthritis

United States, Spain, Australia, Serbia, Germany, Canada, Japan, New Zealand, Hungary, Italy, Sweden, Lithuania, Portugal, Russian Federation, Slovakia
Washington University School of Medicine

Completed

Effects of Antipsychotic Medications on Energy Intake and Expenditure (DLW)

Schizophrenia | Schizoaffective Disorder | Weight Gain

United States
Hospital San Carlos, Madrid

Completed

Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer (PALBOSPAIN)

Breast Cancer

Spain
Novartis Pharmaceuticals

Completed

Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors

Metastatic Breast Cancer

United States
Institut Bergonié

Completed

Efficacy and Safety of PD-0332991 in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (CYCLIGIST)

Advanced Gastrointestinal Stromal Tumors

France
UNC Lineberger Comprehensive Cancer Center
Pfizer

Terminated

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Metastatic Urothelial Carcinoma (UC)

United States
Pfizer

Completed

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Neoplasms | Lymphoma, Non-Hodgkin

United States
UNICANCER
Pfizer

Active, not recruiting

Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients (PALATINE)

Surgery | Breast Cancer Stage IV | Radiotherapy

France
G1 Therapeutics, Inc.

Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female

United States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
Abramson Cancer Center of the University of Pennsylvania

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Adult Solid Tumor | HER2-positive Breast Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative... and other conditions

United States
GlaxoSmithKline
Pfizer

Completed

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors

Cancer

United States
Karolinska Institutet

Completed

Comparison Between Analog Neurocognitive Tests Conducted by a Trained Test Leader Versus Self-administered Digital Tests (PICASU-Eq)

Feasibility | Costs | Neurocognitive Decline | Interviews

Sweden

Search clinical trials for: Palbociclib administered Fasted

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations